Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny
Clinical trial NCT02634060 · COMPLETED
Trial details
- NCT number
- NCT02634060
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-31
- Primary completion
- 2018-06-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.